We use cookies for a better user experience. Read our Privacy Policy
I Agree
Respiratory Devices Market Forecast Report, 2018-2026
As per a report published by the National Institutes of Health (NIH), approximately 12 million adult population is diagnosed with Chronic Obstructive Pulmonary Disease (COPD) annually in the U.S. Further, 120, 000 people die of the cause. As per a statistics provided by Global Asthma Network (GAN), approximately 334 million are, reportedly, suffering from COPD across the globe. In addition, as per data given by the WHO, 3 million people die due to COPD around the world.
Every report by prominent health organization is signaling towards growing incidence of Chronic Obstructive Pulmonary Disease across the world and its adverse impact on health of the people. Some of the significant cases of COPD include respiratory allergies, asthma, occupational lung diseases, and pulmonary hypertension. Prevalence of such diseases is witnessed in middle- and low-income countries.
Dramatic rise in respiratory diseases and subsequent increase in patient pool due to COPD are major factors accelerating uptake of respiratory therapy and respiratory therapy devices. Use of respiratory devices minimizes the risk of heart failure, enhance breathing patterns, and improves mental stamina.
These factors, altogether, are contributing to expansion of the respiratory devices market.
As per a report published by Transparency Market Research, the respiratory devices market is anticipated to growth at a moderate CAGR of 6.5% between 2018 and 2026 (forecast period). In the year 2017, the respiratory devices market stood at a value of US $ 17 billion. If the market scales at predicted CAGR, then the market size is projected to grow equivalent to US$ 31.0 Bn by the end of 2026.
Rising prevalence of sleep apnea and COPD, healthy competition among key player, investment from various stakeholders are major driving factors likely to fuel the global respiratory device and uncertain regulations by government bodies may interfere with the market growth during the forecast period.
Rising awareness regarding application of respiratory devices and associated benefits is expected to boost the market in coming years. Adoption of on-demand and continuous Portable Oxygen Concentrator (POC) in a wide range of applications including emergency medicine is emerging as a fresh growth prospect for expansion of the global respiratory devices market.
Registering the application areas, players operating in the global market are consistently working to bring innovation in the product, providing efficient solution and on subsequently reducing the price of units.
Some of the prominent key players operating in the oxygen therapy devices market are ResMed, Koninklijke Philips N.V, and Vyaire Medical, Inc. (Becton, Dickinson and Company), Smiths Medical (part of Smiths Group plc), Fisher & Paykel Healthcare Limited, Dragerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), Getinge AB, Medtronic plc, and Chart Industries, among others
These companies are introducing products on basis of clinical urgency for greater mobility support for elderly population and growing demand for the portable technology by consumers. Diversified product portfolio is anticipated to gain wide customer traction.
Further, advent of technologically respiratory devices, which offers efficient patient is projected to accelerate the market growth. Technologically advancement in delivery devices has resulted in integration of sensors coupled with pulse dose meters. These devices enable to regulate flow of the oxygen. Adoption of respiratory therapy is growing significantly. The growth rate is attributed to the potential benefits offered by the devices. These benefits include faster response rate, efficient dosing, controlled flow, and greater reliability and durability. These aforementioned factors are likely to propel the industry expansion process.
Growing prevalence of respiratory diseases such as sleep apnea and Chronic Obstructive Pulmonary disorder is anticipated to boost market growth. As per a report published by the WHO, nearly 64 million people across the globe suffers from mild to severe COPD. In addition, COPD is found to be third leading cause of death across the world. Rising demand for protracted treatment and emergency treatment associated with lung diseases in children and adults are likely to boost the market growth during the forecast period.
Further, respiratory therapeutics devices are preferred by medical professionals and physicians for treatment of various types of respiratory disorders. These devices provide immediate medical intervention in case of acute and chronic patient care.
In recent years, North America market has accounted for prominent share in the global respiratory devices market. Prominence of the region is attributed to presence of well-developed healthcare infrastructure, growing awareness among population, and constant technological advancements.
The region is likely to lead in coming years as well, owing to growing patient pool affected by respiratory diseases. Rising prevalence of COPD is anticipated to fuel demand for respiratory devices in the region.
The global respiratory devices market has been segmented as follows:
|
Product Type |
|
|
Therapeutic Devices |
|
|
Diagnostic & Monitoring Devices |
|
|
Application |
|
|
Region |
|
Respiratory Devices Market is expected to reach US$ 31.0 Bn by 2026
Respiratory Devices Market is anticipated to expand at a CAGR of 6.5% during the forecast period
Respiratory Devices Market is driven by rising prevalence of sleep apnea and COPD, healthy competition among key player, investment from various stakeholders
North America market has accounted for prominent share in the global respiratory devices market
Top key players in respiratory devices market are ResMed, Koninklijke Philips N.V, and Vyaire Medical, Inc. (Becton, Dickinson and Company), Smiths Medical (part of Smiths Group plc), Fisher & Paykel Healthcare Limited
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Respiratory Devices Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Global Respiratory Devices Market Analysis and Forecasts, 2016–2026
4.3.1. Market Revenue Projections (US$ Mn)
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.3.4. Key Trends
5. Market Outlook
5.1. Value Chain Analysis
5.2. Regulatory Framework
5.3. Porter’s Five Force Analysis
6. Global Respiratory Devices Market Analysis and Forecasts, by Product Type
6.1. Introduction & Definition
6.2. Market Value Forecast, by Product Type, 2016–2026
6.2.1. Therapeutic Devices
6.2.2. Diagnostic & Monitoring Devices
6.3. Market Attractiveness Analysis
6.3.1. Therapeutic Devices
6.3.2. Diagnostic & Monitoring Devices
7. Global Respiratory Devices Market Analysis and Forecasts, by Therapeutic Devices
7.1. Introduction & Definition
7.2. Market Value Forecast, by Therapeutic Devices, 2016–2026
7.2.1. Drug Delivery Devices
7.2.1.1. Nebulizers
7.2.1.2. Inhalers
7.2.2. Mechanical Ventilators
7.2.2.1. Invasive
7.2.2.2. Non-Invasive
7.2.3. Continuous Positive Airway Pressure (CPAP)
7.2.3.1. Devices
7.2.3.2. Disposables
7.2.4. Resuscitators
7.2.4.1. Reusable
7.2.4.2. Disposables
7.2.5. Humidifiers
7.2.6. Airway Clearance Devices
7.2.7. Oxygen Concentrators
7.2.8. Consumables & Disposables
7.2.9. Others
7.3. Market Attractiveness by Therapeutic Devices
7.3.1. Drug Delivery Devices
7.3.2. Mechanical Ventilators
7.3.3. Continuous Positive Airway Pressure (CPAP)
7.3.4. Resuscitators
7.3.5. Humidifiers
7.3.6. Airway Clearance Devices
7.3.7. Oxygen Concentrators
7.3.8. Consumables & Disposables
7.3.9. Others
8. Global Respiratory Devices Market Analysis and Forecasts, by Diagnostic & Monitoring Devices
8.1. Introduction & Definition
8.2. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
8.2.1. Pulse Oximeters
8.2.2. Capnographs
8.2.3. Spirometers
8.2.4. Polysomnographs (PSG)
8.2.5. Peak Flow Meters
8.2.6. Gas Analyzers
8.2.7. Others
8.3. Market Attractiveness, by Diagnostic & Monitoring Devices
8.3.1. Pulse Oximeters
8.3.2. Capnographs
8.3.3. Spirometers
8.3.4. Polysomnographs (PSG)
8.3.5. Peak Flow Meters
8.3.6. Gas Analyzers
8.3.7. Others
9. Global Respiratory Devices Market Analysis and Forecasts, by Application
9.1. Introduction & Definition
9.2. Market Value Forecast, by Application, 2016–2026
9.2.1. Chronic Obstructive Pulmonary Disease (COPD)
9.2.2. Asthma
9.2.3. Obstructive Sleep Apnea (OSA)
9.2.4. Respiratory Distress Syndrome (RDS)
9.2.5. Cystic Fibrosis
9.2.6. Pneumonia
9.3. Market Attractiveness, by Application
9.3.1. Chronic Obstructive Pulmonary Disease (COPD)
9.3.2. Asthma
9.3.3. Obstructive Sleep Apnea (OSA)
9.3.4. Respiratory Distress Syndrome (RDS)
9.3.5. Cystic Fibrosis
9.3.6. Pneumonia
10. Global Respiratory Devices Market Analysis and Forecasts, by Region
10.1. Market Value Share Analysis, by Region
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
11. North America Respiratory Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2016–2026
11.2.1. Therapeutic Devices
11.2.2. Diagnostic & Monitoring Devices
11.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
11.3.1. Drug Delivery Devices
11.3.1.1. Nebulizers
11.3.1.2. Inhalers
11.3.2. Mechanical Ventilators
11.3.2.1. Invasive
11.3.2.2. Non-Invasive
11.3.3. Continuous Positive Airway Pressure (CPAP)
11.3.3.1. Devices
11.3.3.2. Disposables
11.3.4. Resuscitators
11.3.4.1. Reusable
11.3.4.2. Disposables
11.3.5. Humidifiers
11.3.6. Airway Clearance Devices
11.3.7. Oxygen Concentrators
11.3.8. Consumables & Disposables
11.3.9. Others
11.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
11.4.1. Pulse Oximeters
11.4.2. Capnographs
11.4.3. Spirometers
11.4.4. Polysomnographs (PSG)
11.4.5. Peak Flow Meters
11.4.6. Gas Analyzers
11.4.7. Others
11.5. Market Value Forecast, by Application, 2016–2026
11.5.1. Chronic Obstructive Pulmonary Disease (COPD)
11.5.2. Asthma
11.5.3. Obstructive Sleep Apnea (OSA)
11.5.4. Respiratory Distress Syndrome (RDS)
11.5.5. Cystic Fibrosis
11.5.6. Pneumonia
11.6. Market Value Forecast, by Country, 2016–2026
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Therapeutic Devices
11.7.2. By Diagnostic & Monitoring Devices
11.7.3. By Application
11.7.4. By Country
12. Europe Respiratory Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2016–2026
12.2.1. Therapeutic Devices
12.2.2. Diagnostic & Monitoring Devices
12.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
12.3.1. Drug Delivery Devices
12.3.1.1. Nebulizers
12.3.1.2. Inhalers
12.3.2. Mechanical Ventilators
12.3.2.1. Invasive
12.3.2.2. Non-invasive
12.3.3. Continuous Positive Airway Pressure (CPAP)
12.3.3.1. Devices
12.3.3.2. Disposables
12.3.4. Resuscitators
12.3.4.1. Reusable
12.3.4.2. Disposables
12.3.5. Humidifiers
12.3.6. Airway Clearance Devices
12.3.7. Oxygen Concentrators
12.3.8. Consumables & Disposables
12.3.9. Others
12.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
12.4.1. Pulse Oximeters
12.4.2. Capnographs
12.4.3. Spirometers
12.4.4. Polysomnographs (PSG)
12.4.5. Peak Flow Meters
12.4.6. Gas Analyzers
12.4.7. Others
12.5. Market Value Forecast, by Application, 2016–2026
12.5.1. Chronic Obstructive Pulmonary Disease (COPD)
12.5.2. Asthma
12.5.3. Obstructive Sleep Apnea (OSA)
12.5.4. Respiratory Distress Syndrome (RDS)
12.5.5. Cystic Fibrosis
12.5.6. Pneumonia
12.6. Market Value Forecast, by Country / Sub-region, 2016–2026
12.6.1. Germany
12.6.2. France
12.6.3. U.K.
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Therapeutic Devices
12.7.2. By Diagnostic & Monitoring Devices
12.7.3. By Application
12.7.4. By Country/Sub-region
13. Asia Pacific Respiratory Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2016–2026
13.2.1. Therapeutic Devices
13.2.2. Diagnostic & Monitoring Devices
13.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
13.3.1. Drug Delivery Devices
13.3.1.1. Nebulizers
13.3.1.2. Inhalers
13.3.2. Mechanical Ventilators
13.3.2.1. Invasive
13.3.2.2. Non-Invasive
13.3.3. Continuous Positive Airway Pressure (CPAP)
13.3.3.1. Devices
13.3.3.2. Disposables
13.3.4. Resuscitators
13.3.4.1. Reusable
13.3.4.2. Disposables
13.3.5. Humidifiers
13.3.6. Airway Clearance Devices
13.3.7. Oxygen Concentrators
13.3.8. Consumables & Disposables
13.3.9. Others
13.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
13.4.1. Pulse Oximeters
13.4.2. Capnographs
13.4.3. Spirometers
13.4.4. Polysomnographs (PSG)
13.4.5. Peak Flow Meters
13.4.6. Gas Analyzers
13.4.7. Others
13.5. Market Value Forecast, by Application, 2016–2026
13.5.1. Chronic Obstructive Pulmonary Disease (COPD)
13.5.2. Asthma
13.5.3. Obstructive Sleep Apnea (OSA)
13.5.4. Respiratory Distress Syndrome (RDS)
13.5.5. Cystic Fibrosis
13.5.6. Pneumonia
13.6. Market Value Forecast, by Country/Sub-region, 2016–2026
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of APAC
13.7. Market Attractiveness Analysis
13.7.1. By Therapeutic Devices
13.7.2. By Diagnostic & Monitoring Devices
13.7.3. By Application
13.7.4. By Country/Sub-region
14. Latin America Respiratory Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2016–2026
14.2.1. Therapeutic Devices
14.2.2. Diagnostic & Monitoring Devices
14.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
14.3.1. Drug Delivery Devices
14.3.1.1. Nebulizers
14.3.1.2. Inhalers
14.3.2. Mechanical Ventilators
14.3.2.1. Invasive
14.3.2.2. Non-Invasive
14.3.3. Continuous Positive Airway Pressure (CPAP)
14.3.3.1. Devices
14.3.3.2. Disposables
14.3.4. Resuscitators
14.3.4.1. Reusable
14.3.4.2. Disposables
14.3.5. Humidifiers
14.3.6. Airway Clearance Devices
14.3.7. Oxygen Concentrators
14.3.8. Consumables & Disposables
14.3.9. Others
14.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
14.4.1. Pulse Oximeters
14.4.2. Capnographs
14.4.3. Spirometers
14.4.4. Polysomnographs (PSG)
14.4.5. Peak Flow Meters
14.4.6. Gas Analyzers
14.4.7. Others
14.5. Market Value Forecast, by Application, 2016–2026
14.5.1. Chronic Obstructive Pulmonary Disease (COPD)
14.5.2. Asthma
14.5.3. Obstructive Sleep Apnea (OSA)
14.5.4. Respiratory Distress Syndrome (RDS)
14.5.5. Cystic Fibrosis
14.5.6. Pneumonia
14.6. Market Value Forecast, by Country/Sub-region, 2016–2026
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of LATAM
14.7. Market Attractiveness Analysis
14.7.1. By Therapeutic Devices
14.7.2. By Diagnostic & Monitoring Devices
14.7.3. By Application
14.7.4. By Country / Sub-region
15. Middle East & Africa Respiratory Devices Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2016–2026
15.2.1. Therapeutic Devices
15.2.2. Diagnostic & Monitoring Devices
15.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
15.3.1. Drug Delivery Devices
15.3.1.1. Nebulizers
15.3.1.2. Inhalers
15.3.2. Mechanical Ventilators
15.3.2.1. Invasive
15.3.2.2. Non-Invasive
15.3.3. Continuous Positive Airway Pressure (CPAP)
15.3.3.1. Devices
15.3.3.2. Disposables
15.3.4. Resuscitators
15.3.4.1. Reusable
15.3.4.2. Disposables
15.3.5. Humidifiers
15.3.6. Airway Clearance Devices
15.3.7. Oxygen Concentrators
15.3.8. Consumables & Disposables
15.3.9. Others
15.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
15.4.1. Pulse Oximeters
15.4.2. Capnographs
15.4.3. Spirometers
15.4.4. Polysomnographs (PSG)
15.4.5. Peak Flow Meters
15.4.6. Gas Analyzers
15.4.7. Others
15.5. Market Value Forecast, by Application, 2016–2026
15.5.1. Chronic Obstructive Pulmonary Disease (COPD)
15.5.2. Asthma
15.5.3. Obstructive Sleep Apnea (OSA)
15.5.4. Respiratory Distress Syndrome (RDS)
15.5.5. Cystic Fibrosis
15.5.6. Pneumonia
15.6. Market Value Forecast, by Country/Sub-region, 2016–2026
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Israel
15.6.4. Rest of MEA
15.7. Market Attractiveness Analysis
15.7.1. By Therapeutic Devices
15.7.2. By Diagnostic & Monitoring Devices
15.7.3. By Application
15.7.4. By Country / Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles
16.2.1. ResMed Inc.
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. SWOT Analysis
16.2.1.5. Strategic Overview
16.2.2. Smiths Medical (part of Smiths Group plc)
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2..2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. SWOT Analysis
16.2.2.5. Strategic Overview
16.2.3. Fisher & Paykel Healthcare Limited
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3..2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. SWOT Analysis
16.2.3.5. Strategic Overview
16.2.4. Dragerwerk AG & Co. KGaA
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4..2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. SWOT Analysis
16.2.4.5. Strategic Overview
16.2.5. GE Healthcare (part of General Electric Company)
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5..2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. SWOT Analysis
16.2.5.5. Strategic Overview
16.2.6. Getinge AB
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6..2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. SWOT Analysis
16.2.6.5. Strategic Overview
16.2.7. Medtronic plc
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7..2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. SWOT Analysis
16.2.7.5. Strategic Overview
16.2.8. Koninklijke Philips N.V.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8..2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. SWOT Analysis
16.2.8.5. Strategic Overview
16.2.9. Chart Industries
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9..2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. SWOT Analysis
16.2.9.5. Strategic Overview
16.2.10. ResMed Inc.
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Financial Overview
16.2.10.3. Product Portfolio
16.2.10.4. SWOT Analysis
16.2.10.5. Strategic Overview
16.2.11. Vyaire Medical Inc. (Becton, Dickinson and Company)
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Financial Overview
16.2.11.3. Product Portfolio
16.2.11.4. SWOT Analysis
16.2.11.5. Strategic Overview
List of Tables
Table 01: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 02: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Device Type, 2016–2026
Table 03: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 04: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 05: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by CPAP, 2016–2026
Table 06: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 07: Global Diagnostic & Monitoring Respiratory Devices Market Size (US$ Mn) Forecast, by Device Type, 2016–2026
Table 08: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 09: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 10: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 11: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 12: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Device, 2016–2026
Table 13: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilator, 2016–2026
Table 14: North America Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 15: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitator, 2016–2026
Table 16: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 17: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 19: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 20: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Device, 2016–2026
Table 21: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 22: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 23: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 24: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Devices, 2016–2026
Table 25: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 26: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 27: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 28: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 29: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 30: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 31: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 32: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 33: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 34: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 35: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 36: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 37: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 38: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 39: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 40: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 41: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 42: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 43: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 44: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 45: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 46: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 47: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 48: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 49: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
List of Figures
Figure 01: Global Respiratory Devices Market Size ($ Million) and Distribution by Geography, 2017 and 2026
Figure 02: Global Respiratory Devices
Figure 03: Top 3 Trends
Figure 04: Global Respiratory Devices market, by Region (2017)
Figure 05: Global Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 06: Market Value Share by Product Type (2017) Value (US$ Mn)
Figure 07: Market Value Share by Application (2017) Value (US$ Mn)
Figure 08: Market Value Share by Geography (2017) Value (US$ Mn)
Figure 09: Value Chain Analysis
Figure 10: Global Respiratory Devices Market Value Share, by Product Type, 2017 and 2026
Figure 11: Global Therapeutic Respiratory Devices Market Value Share, by Device Type, 2017 and 2026
Figure 12: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Delivery Devices, 2016–2026
Figure 13: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Mechanical Ventilators, 2016–2026
Figure 14: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CPAP, 2016–2026
Figure 15: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Resuscitators, 2016–2026
Figure 16: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Humidifiers, 2016–2026
Figure 17: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Airway Clearance Devices, 2016-2026
Figure 18: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oxygen Concentrators, 2016–2026
Figure 19: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables & Disposables, 2016-2026
Figure 20: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 21: Global Therapeutic Respiratory Devices Market Attractiveness Analysis, by Device Type, 2018-2026
Figure 22: Global Diagnostic & Monitoring Respiratory Devices Market Value Share, by Device Type, 2017 and 2026
Figure 23: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pulse Oximeters, 2016–2026
Figure 24: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Capnographs, 2016–2026
Figure 25: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Spirometers, 2016–2026
Figure 26: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Polysomnographs (PSG), 2016–2026
Figure 27: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Peak Flow Meters, 2016–2026
Figure 28: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gas Analyzers, 2016–2026
Figure 29: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 30: Global Diagnostic & Monitoring Respiratory Devices Market Attractiveness Analysis, by Device Type, 2018-2026
Figure 31: Global Respiratory Devices Market Value Share, by Application, 2017 and 2026
Figure 32: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by COPD, 2016–2026
Figure 33: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Asthma, 2016–2026
Figure 34: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Obstructive Sleep Apnea, 2016–2026
Figure 35: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Respiratory Distress Syndrome, 2016–2026
Figure 36: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cystic Fibrosis, 2016–2026
Figure 37: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pneumonia, 2016–2026
Figure 38: Global Respiratory Devices Market Attractiveness Analysis, by Application, 2018-2026
Figure 39: Global Respiratory Devices Market Value Share, by Region, 2017 and 2026
Figure 40: Global Respiratory Devices Market Attractiveness Analysis, by Region, 2018-2026
Figure 41: North America Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 42: North America Respiratory Devices Market Share Analysis, by Product Type, 2017 and 2026
Figure 43: North America Respiratory Devices Market Share Analysis, by Therapeutic Devices Types, 2017 and 2026
Figure 44: North America Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices Type
Figure 45: North America Respiratory Devices Market Share Analysis, by Diagnostics & Monitoring Devices Type, 2017 and 2026
Figure 46: North America Respiratory Devices Market Attractiveness Analysis, by Diagnostics & Monitoring Type
Figure 47: North America Respiratory Devices Market Share Analysis, by Application, 2017 and 2026
Figure 48: North America Respiratory Devices Market Attractiveness Analysis, by Application, 2018-2026
Figure 49: Europe Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 50: Europe Respiratory Devices Market Share Analysis, by Product Type, 2017 and 2026
Figure 51: Europe Respiratory Devices Market Share Analysis, by Therapeutic Devices Type, 2017 and 2026
Figure 52: Europe Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices
Figure 53: Europe Respiratory Devices Market Share Analysis, by Diagnostics & Monitoring Devices Type, 2017 and 2026
Figure 54: Europe Respiratory Devices Market Attractiveness Analysis, by Diagnostics & Monitoring Type
Figure 55: Europe Respiratory Devices Market Share Analysis, by Application, 2017 and 2026
Figure 56: Europe Respiratory Devices Market Attractiveness Analysis, by Application
Figure 57: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 58: Asia Pacific Respiratory Devices Market Share Analysis, by Product Type, 2017 and 2026
Figure 59: Asia Pacific Respiratory Devices Market Share Analysis, by Therapeutic Devices Type, 2017 and 2026
Figure 60: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices Type
Figure 61: Asia Pacific Respiratory Devices Market Share Analysis, by Diagnostics & Monitoring Devices Type, 2017 and 2026
Figure 62: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Diagnostics & Monitoring Type
Figure 63: Asia Pacific Respiratory Devices Market Share Analysis, by Application, 2017 and 2026
Figure 64: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Application
Figure 65: Latin America Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 66: Latin America Respiratory Devices Market Share Analysis, by Product Type, 2017 and 2026
Figure 67: Latin America Respiratory Devices Market Share Analysis, by Therapeutic Devices Types, 2017 and 2026
Figure 68: Latin America Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices Type
Figure 69: Latin America Respiratory Devices Market Share Analysis, by Diagnostics & Monitoring Devices Type, 2017 and 2026
Figure 70: Latin America Respiratory Devices Market Attractiveness Analysis, by Diagnostics & Monitoring Type
Figure 71: Latin America Respiratory Devices Market Share Analysis, by Application, 2017 and 2026
Figure 72: Latin America Respiratory Devices Market Attractiveness Analysis, by Application
Figure 73: MEA Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 74: MEA Respiratory Devices Market Share Analysis, by Product Type, 2017 and 2026
Figure 75: MEA Respiratory Devices Market Share Analysis, by Therapeutic Devices Types, 2017 and 2026
Figure 76: MEA Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices Type
Figure 77: MEA Respiratory Devices Market Share Analysis, by Diagnostics & Monitoring Devices Type, 2017 and 2026
Figure 78: MEA Respiratory Devices Market Attractiveness Analysis, by Diagnostics & Monitoring Type
Figure 79: MEA Respiratory Devices Market Share Analysis, by Application, 2017 and 2026
Figure 80: MEA Respiratory Devices Market Attractiveness Analysis, by Application
Figure 81: Global Respiratory Devices Market Share Analysis, by Company (2017)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes